California
Duarte; City of Hope
A Pilot Study to Determine the Reliability of Telomerase RNA Detection in the Expressed Prostatic Secretion of Men Undergoing Prostatic Biopsy in Confirming Cancer Diagnosis
Duarte; City of Hope
CALGB 90203: A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
Duarte; City of Hope
PHII-84, NCI#7659; A Randomized, Phase II Study of GW786034 (Pazopanib) in Stage DO Relapsed Androgen Sensitive Prostate Cancer Following Limited GnRH Agonist Therapy
Duarte; City of Hope
RTOG 0534: A Phase III Trial of Short Term Androgen Deprivation with Pelvis Lymph Node or Prostate Bed Only Radiotherapy (SPORT)in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy
Duarte; City of Hope
Long Term Follow Up after Prostate Cancer
Duarte; City of Hope
Erectile Dysfunction Recovery in Men age
Duarte; City of Hope
SWOG 9346: Intermittent Androgen Deprivation in Patients with Stage D2 Prostate Cancer, Phase III
Duarte; City of Hope
Androgen Deprivation and Localized Radiotherapy to Metastases in Patients with Oligometastatic Hormone - Sensitive Prostate Cancer
Duarte; City of Hope
Pre-Surgical EPS Biomarkers as Predictors of Recurrence
Duarte; City of Hope
Prostate Cancer Outcomes by Race and Treatment Site
Duarte; City of Hope
Prostate Cancer Database
Fountain Valley; Research Center
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
Los Angeles; Cedars Sinai Medical Center
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Pleasant Hill; Bay Area cancer Research Group, LLC
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Sacramento; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Torrance; Western Clinical Research, Inc.
Attention: Men with Prostate Cancer
Connecticut
Middlebury; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Middlebury; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Various Cities; Research Center
Prostate Cancer Study CEPO906A2229
Florida
Aventura; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Aventura; South Florida Medical Research, Inc.
Phase IV, Hormone Refractory Prostate Cancer Study
Aventura; South Florida Medical Research
Phase II, Clinical Trial For Patients with Prostate Cancer or Breast Cancer with Metastatic Disease
Sarasota; Florida Urology Specialists
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
St. Petersburg; Advent Clinical Research Centers, Inc.
Male Hot Flash Study
Tallahassee; Southeastern Research Group, Inc.
A Phase III Study of Study Drug on Prolonging Bone Metastasis-Free Survival in Men with Hormone- Refractory Prostate Cancer
Various Cities; Research Center
Prostate Cancer Study CEPO906A2229
Georgia
Various Cities; Research Center
Prostate Cancer Study CEPO906A2229
Illinois
Chicago; University Of Chicago
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Elgin; Sherman Health Systems![[*]](../images/newtiny.gif)
Phase III Study of Docetaxel and Atrasentan versus Docetaxel and Placebo For Patients with Advanced Hormone Refractory Prostate Cancer
Elgin; Sherman Health Systems
ECOG E5805 "A phase I trial of E7389 (Halichondrin B Analog), in patients with metastatic hormone refractory prostate cancer"
Peoria; Specialty Care Research
Prostate Cancer Study
Peoria; Specialty Care Research
Prostate Cancer And Hot Flashes
Indiana
Jeffersonville; Metropolitan Urology, PSC.
Have you been diagnosed with prostate cancer? Has the cancer spread to the bone? Is your PSA rising? If so you may qualify for a clinical research trial for the treatment of bone metastases in men with hormone-refractory prostate cancer.
Maryland
Baltimore; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Baltimore; The Bunting Blaustein Cancer Research Building
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Minnesota
Chaska; Ridgeview Research
Prostate Cancer
Montana
Billings; Research Center
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
Nevada
Las Vegas; Sheldon Freedman, MD LTD
Prostate Cancer - High Risk, Men Age 18 and Above, Infused Antibody Plus Hormone Therapy Prior to Prostatectomy, 4 Month Research Study
Las Vegas; Sheldon Freedman, MD LTD
Prostate Cancer - Prevention of Bone Fractures, Men Age 50 and Above, 2 Year Oral Medication Research Study
Las Vegas; Sheldon Freedman, MD LTD
Prostate Cancer - Advanced, Men Age 18 and Above, 12 Week Injected Medication
Las Vegas; Sheldon Freedman, MD LTD
Benign Prostatic Hyperplasia (BPH), Men Age 45-75, 4 Month Prostate Injection Research Study
New Jersey
Lawrenceville; AdvanceMed Research
Prostate Cancer that requires Hormone therapy.
Lawrenceville; AdvanceMed Research
Do you have Prostate Cancer?
Voorhees; Delaware Valley Urology, LLC
Have you been diagnosed with Prostate Cancer, Chronic Prostatitis, or Benign Prostatic Hyperplasia (BPH)?
New Mexico
Albuquerque; Urology Group of New Mexico
A study to treat men with Prostate Cancer with bone metastasis who are on androgen deprivation treatment.
Farmington; Research Center
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
New York
Bronx; Biomedical Research Alliance of New York
Prostate Cancer - Adult Men
Bronx; Biomedical Research Alliance of New York
Prostate Cancer - Adult Men
Bronx; Research Center
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
Bronx; Biomedical Research Alliance of New York
Montefiore Medical Center is conducting a clinical study to assess the safety and efficacy of an experimental drug in men with advanced prostate cancer.
New Hyde Park; Biomedical Research Alliance of New York
Patients with Metastatic Castration-Resistant Prostate Cancer (CRPC) who have failed Docetaxel-Based Chemotherapy - Adults
New York; Mount Sinai Medical Center
Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients with Radiorecurrent Prostate Cancer
New York; Mount Sinai Medical Center
Neoadjuvant/Adjuvant Docetaxel and Estramustine in Combination with Brachytherapy and Three-Dimensional Conformal Radiotherapy
New York; Mount Sinai Medical Center
Efficacy of combined prophylactic and on demand Sildenafil usage in potent men undergoing brachytherapy and hormonal therapy for localized prostate cancer.
New York; Columbia University
A Phase I trial of combined Taxotere/Estramustine + Mitoxantrone/Prednisone in Hormone Refractory Prostate Cancer
New York; Mount Sinai Medical Center
Docetaxel and Estramustine versus Mitoxantrone and Prednisone for Advanced Hormone Refractory Prostate Cancer, Phase III
Sponsor: CALGB
New York; Mount Sinai Medical Center
A Phase II Study of Weekly Taxol and Estramustine for Treatment of Prostate Cancer Micrometastases after Radical Prostatectomy or Salvage Radiation Therapy
New York; Mount Sinai Medical Center
Diagnosis of Prostate Cancer Using Multigene Expression Signatures
New York; Memorial Sloan-Kettering Cancer Center-Sidney Kimmel Center
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Staten Island; Staten Island Urological Research, P.C.
Prostate Cancer Prevention Clinical Trial
Staten Island; Staten Island Urological Research, P.C.
A Randomized, Double Blind, Placebo Controlled Trial of Immunotherapy with Autologous Antigen-Loaded Dendritic Cells For Asymptomatic Metastatic Hormone Refractory Prostate Cancer.
Staten Island; Staten Island Urological Research, P.C.
Prostate Cancer Bone Loss Study.
Staten Island; Staten Island Urological Research, PC
Concerned about bone loss associated with your prostate cancer therapy?
Staten Island; Staten Island Urological Research, P.C.
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind , Dose-Ranging Clinical Trial To Study The Efficacy And Safety of 5, 15 or 25mg/day CyPat (Cyproterone Acetate) for the Treatment of Hot Flashes Following Surgical or Medical Castration of Prostate Cancer Patients
Staten Island; Staten Island Urological Research, P.C.
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab on Prolonging Bone Metastasis-Free Survival in Men with Hormone Refractory Prostate Cancer
Staten Island; Staten Island Urological Research, P.C.
A Phase 3, Randomized, Open-label Study Evaluating DN-101 in Combination with Docetaxel in Androgen Independent Prostate Cancer (AIPC) (ASCENT2)
Staten Island; Staten Island Urological Research, P.C.
Prostate cancer trial
Various Cities; Research Center
Prostate Cancer Study CEPO906A2229
Various Cities; Research Center
Prostate Cancer Study CLBH589C2208
North Carolina
Winston-Salem; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Winston-Salem; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
North Dakota
Bismarck; St. Alexius Medical Center
A research study for prostate cancer patients
Ohio
Canton; Research Center
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
Oregon
Portland; Research Center
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
Pennsylvania
Altoona; Blair Medical Associates
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
Hershey; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Hershey; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Philadelphia; Fox Chase Cancer Center
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Texas
Fort Worth; Research Center
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
Houston; Research Center
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Adenocarcinoma Of The Prostate
Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplaston A10 And AS2-1 Private Capsules In Patients
With Incurable, Stage C Or D Adenocarcinoma Of The Prostate
Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Adenocarcinoma Of The Prostate
Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplaston A10 And AS2-1 Private Capsules In Combination With Total Androgen Blockade In Patients With Adenocarcinoma Of The Prostate
Various Cities; Research Center
Prostate Cancer Study CEPO906A2229
Washington
Seattle; Research Center
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
Seattle; Research Site:
A Study of Epothilone D in Patients With Metastatic Prostate Cancer
Seattle; Seattle Cancer Care Alliance
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Tacoma; Research Center
Phase 2 Research Study Investigating the Safety and Effectiveness of ZK-Epothilone in Patients with Metastatic prostate cancer
Wisconsin
Madison; University Of Wisconsin Paul P Carbone Comprehensive Ca Ctr
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Various Cities; Research Center
Prostate Cancer Study CLBH589C2208
International
Edmonton, AB, Canada; Cross Cancer Institute
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Montreal, QC, Canada; Hospital Notre Dame
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Arhus N, Denmark; Urologisk afd K
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Herlev, Denmark; Department of Oncology
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Herlev, Denmark; Department of Urology
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Lyon, France; Research Site:
A Study of Pertuzumab in Patients With Prostate Cancer.
Montpellier, France; Centre Val D'Aurelle-Parc Lamarque
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Paris, France; Hopital Europeen Georges Pompidou
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Villejuif Cedex, France; Institut Gustave Roussy
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Berlin, Germany; Research Site:
A Study of Pertuzumab in Patients With Prostate Cancer.
Parma, Italy; Research Site:
A Study of Pertuzumab in Patients With Prostate Cancer.
Roma, Italy; Research Site:
A Study of Pertuzumab in Patients With Prostate Cancer.
Rome, Italy; Azienda Ospedaliera S. Camillo Forlanini
Phase II Study of Dasatinib (BMS-354825) for Androgen - Deprived Progressive Prostate Cancer
Oslo, Norway; Kreftsenteret, Ullevål Universitetssykehus
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Barcelona, Spain; Comité Ético de Investigación Clínica,
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Barcelona, Spain; Research Site:
A Study of Pertuzumab in Patients With Prostate Cancer.
Lleida, Spain; Hospital Arnau de Vilanova
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Valencia, Spain; Comité Ético de Investigación Clínica,
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Valencia, Spain; Comité Ético de Investigación Clínica,
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Valencia, Spain; Research Site:
A Study of Pertuzumab in Patients With Prostate Cancer.
Bristol, United Kingdom; Research Site:
A Study of Pertuzumab in Patients With Prostate Cancer.
Cardiff, United Kingdom; Research Site:
A Study of Pertuzumab in Patients With Prostate Cancer.
Glasgow, United Kingdom; The Beatson West of Scotland Cancer Centre
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Manchester, United Kingdom; The Christie Hospital
A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
Sutton, United Kingdom; Research Site:
A Study of Pertuzumab in Patients With Prostate Cancer.
